Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro

HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS

R. Palmer Beasley, Chia‐Chin Lin, Lu‐Yu Hwang et al. · The Lancet · 1981 · 2.9K citations

Medicine, Internal Medicine, Oncology +10

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues.

Shin-Lian Doong, Chi‐Wei Tsai, Raymond F. Schinazi et al. · Proceedings of the National Academy of Sciences · 1991 · 516 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′,3′-dideoxycytidine

C H Chen, Ying‐Chih Cheng · Journal of Biological Chemistry · 1989 · 277 citations · Full text

Life Sciences, Biochemistry, Pharmacology +12

Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes

Raymond F. Schinazi, C. K. CHU, A Peck et al. · Antimicrobial Agents and Chemotherapy · 1992 · 265 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

Hugo Soudeyns, Xiaojian Yao, Qing Gao et al. · Antimicrobial Agents and Chemotherapy · 1991 · 236 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16